All Stories

  1. APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy

    Article • Journal of Pain Research, March 2019, Dove Medical Press

    David Soergel

  2. A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

    Article • Journal of Pain Research, October 2017, Dove Medical Press

    Monica Salamea, David Soergel